ScholarLens Back to search
2000•Nuclear Medicine CommunicationsRequires access

26. Safe effective high activity radiolabelling of monoclonal antibodies for radioimmunotherapy: 131I-ANTI-CD 20 monoclonal antibody therapy of non-Hodgkinʼs lymphoma

Andrew A. Martindale

Open publisher page 0 citations

Abstract

s: Abstracts of the 30th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine

About this research paper

What this paper is about

s: Abstracts of the 30th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

s: Abstracts of the 30th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine

Key concepts: Radioimmunotherapy, Monoclonal antibody, Lymphoma, Medicine, Antibody, Cancer research, Immunology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
26. Safe effective high activity radiolabelling of monoclonal antibodies for radioimmunotherapy: 131I-ANTI-CD 20 monoclonal antibody therapy of non-Hodgkinʼs lymphoma — Research Paper | ScholarLens